IXICO (LON:IXI) Stock Price Crosses Below 200-Day Moving Average – What’s Next?

IXICO plc (LON:IXI)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 8.57 and traded as low as GBX 8. IXICO shares last traded at GBX 8, with a volume of 6,847 shares changing hands.

IXICO Trading Down 5.9%

The stock has a fifty day moving average of GBX 8.41 and a two-hundred day moving average of GBX 8.57. The company has a market capitalization of £17.52 million, a PE ratio of -4.10, a PEG ratio of -0.38 and a beta of 0.13. The company has a current ratio of 2.83, a quick ratio of 4.90 and a debt-to-equity ratio of 5.22.

IXICO (LON:IXI) last issued its earnings results on Tuesday, May 19th. The company reported GBX (1.21) earnings per share (EPS) for the quarter. IXICO had a negative return on equity of 16.18% and a negative net margin of 24.98%.The firm had revenue of GBX 395 million during the quarter. As a group, sell-side analysts anticipate that IXICO plc will post -289.3584879 earnings per share for the current fiscal year.

Insider Activity at IXICO

In other IXICO news, insider Mark Warne bought 50,006 shares of IXICO stock in a transaction that occurred on Wednesday, July 15th. The shares were bought at an average price of GBX 8 per share, with a total value of £4,000.48. Corporate insiders own 3.05% of the company’s stock.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.